Deakin University
Browse

A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).

Version 2 2024-06-06, 05:21
Version 1 2023-03-17, 05:05
conference contribution
posted on 2024-06-06, 05:21 authored by Ann LivingstoneAnn Livingstone
A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).

History

Journal

Neuro-Oncology

ISSN

1522-8517

Publication classification

E3.1 Extract of paper

Title of proceedings

Neuro-Oncology

Publisher

Oxford University Press (OUP)

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC